INNOTHERA is a French centennial healthcare company, specialized in treating everyday pathologies and diseases. Founded in 1913 as Laboratoires Chantereau by a visionary pharmacist, René Chantereau, the company has expanded its presence to 100 countries with nearly 1,500 employees. Renamed INNOTHERA in 1935, it is currently led by Arnaud Gobet, the founder's grandson, carrying on the legacy of humanistic values and unique expertise across various medical, industrial, R&D, marketing, and commercial fields. INNOTHERA operates in five primary areas, including elastic vein compression, orthopedics, podiatry, hygiene and protection, as well as medications for women's everyday health, venous insufficiency, common infections, and mineral-calcium imbalances. The company lies at the intersection of the pharmaceutical industry, with 94% of its medications distributed globally, and the medical devices sector, striving for innovation in patient care. With approximately 1,000 employees working across five sites in France and technical-commercial representatives covering the entire country, INNOTHERA is deeply invested in enhancing healthcare products and services. It presents an attractive investment opportunity within the Health Care, Medical Devices, and Pharmaceutical industries for venture capitalists seeking to support advancements in everyday healthcare.
There is no investment information
No recent news or press coverage available for INNOTHERA.